AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Melexis N.V.

Earnings Release Apr 20, 2017

3975_10-q_2017-04-20_31e3f3a3-60f6-4c18-b5f5-0d9949442983.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

Press release

Melexis Q1 2017 results – First quarter sales growth of 13%

Intermediate declaration by the Board of Directors

Ieper, Belgium – April 20th, 2017, 07.00 hrs CET

Sales for the first quarter of 2017 were 123.6 million EUR, an increase of 13% compared to the same quarter of the previous year and an increase of 3% compared to the previous quarter.

The EUR/USD exchange rate evolution had a positive impact of 2%, both compared to the same quarter of last year and the previous quarter.

Gross margin was 56.6 million EUR, an increase of 15% compared to the same quarter of last year and an increase of 3% compared to the previous quarter.

R&D expenses were 13.7% of sales, G&A was at 4.5% of sales and Selling was at 2.1% of sales. The operating result was 31.5 million EUR, an increase of 14% compared to the same quarter of last year and an increase of 7% compared to the previous quarter.

Net income was 25.4 million EUR or 0.63 EUR per share, an increase of 11% compared to 22.8 million EUR or 0.57 EUR per share in the first quarter of 2016 and an increase of 1% compared to the previous quarter.

Outlook

Melexis expects sales in the second quarter of 2017 to be around the level of 127 million EUR. For the full year 2017, Melexis expects sales growth to be between 11% and 15%, a gross profit margin around 45% and an operating margin around 25%, all taking into account a EUR/USD exchange rate of 1.07.

Business comment – Françoise Chombar, CEO:

"Melexis started the year on the right track with a year over year sales growth of 13%. A growing order book provides confidence in our guidance for the full year. Our sensor interfaces and magnetic sensors were the main growth drivers for the quarter. I am especially pleased with the performance of current sensors both in our main automotive and also our industrial markets. This strong growth confirms we are ready for the accelerating automotive trend towards more electrification and are well-positioned to meet existing and future customer needs. In addition this demonstrates our increased diversification towards other markets.

Other outperforming product lines percentage-wise were fan drivers, pressure sensors, rain-light sensors and 3D time-of-flight sensors.

Sales to automotive customers represented 89% of total sales. The portion of standard product (ASSPs) sales represented 60% of total sales.''

Financial Calendar

  • Dividend pay date: April 27, 2017 (ex coupon on April 25, 2017)
  • Analyst Day: May 3, 2017
  • Publication Q2/HY1 2017 Results: August 2, 2017
  • Publication Q3 2017 Results: October 25, 2017
  • Publication FY 2017 Results: February 7, 2018

The company's results will be discussed in a conference call on Thursday, April 20th , 2017 at 17 hrs CET. The conference call will be in English. You have to register for this conference call in advance. You can register by clicking on the following link and filling out the requested information: https://eventreg3.conferencing.com/inv/reg.html?Acc=034060&Conf=370408 Conference ID: 961686.

After registration, you will receive the conference call number, a participant user pin, conference pin and instructions on how to join the conference call. For security purposes all participants must register individually if they wish to join the call.

A replay number for this call is available for 7 days after the end of the conference call. The replay number for this call is +32 2 290 17 05, access code: 961686.

For further information: Investor Relations Phone: +32 13 67 07 79 Fax: +32 13 67 21 34 Email: [email protected]

About Melexis

Combining a passion for technology with truly inspired engineering, Melexis designs, develops and delivers innovative micro-electronic solutions that enable designers to turn ideas into applications that support the best imaginable future. The company's advanced mixed-signal semiconductor sensor and actuator components address the challenges of integrating sensing, driving and communication into next-generation products and systems that improve safety, raise efficiency, support sustainability and enhance comfort. Melexis is headquartered in Belgium and employs over 1,100 people in 19 locations worldwide. The company is publicly traded on Euronext Brussels (MELE). For more information, visit www.melexis.com

Disclaimer

Except for those statements that report the Company's historical results, the statements being made are forward looking statements. Actual results could differ materially from those projected in the forward-looking statements. Factors which could cause actual results to differ from expectations include the following: volatility in supply and demand affecting revenues and market prices, price and availability of silicon foundry, assembly and test prices, assembly and test subcontract capacity required to meet financial targets and/or meet backlog requirements, risks and delays associated with bringing up new production capabilities or with deliveries from subcontractors, timing and market acceptance of new products, increased expenses associated with new product acceptance of new products, increased expenses associated with new product introductions of process changes, delays in developing or achieving volume production of new products, which can result in delays or failure to contribute to revenues and profits, ability of the Company to maintain its customer and vendor base and delays in and/or inability in raising additional capital.

Consolidated Income Statement

CONFORM IFRS Quarter ended
31/03/2017
Quarter ended
31/03/2016
Quarter ended
31/12/2016
Year ended
31/12/2016
in k EUR audited audited
Sales 123,561 109,425 120,021 456,285
Cost of sales -66,954 -60,142 -64,819 -247,737
Gross Margin 56,606 49,283 55,202 208,548
R&D -16,948 -14,746 -17,077 -63,989
G&A -5,572 -4,717 -5,881 -20,944
Selling -2,561 -2,286 -2,849 -9,557
Other operating result 311
Operating result 31,525 27,534 29,396 114,369
Financial result -1,276 -1,094 522 -1,293
Income before taxes 30,249 26,440 29,918 113,076
Income taxes -4,806 -3,605 -4,825 -16,819
Net income 25,442 22,836 25,093 96,257
Net income per share in EUR 0.63 0.57 0.62 2.38

Consolidated Statement of Financial Position

CONFORM IFRS Quarter ended
31/03/2017
Quarter ended
31/03/2016
Year ended
31/12/2016
in k EUR audited
Current Assets :
Cash and cash equivalents 92,045 89,981 75,789
Current investments 49 158
A/R Trade 60,517 52,834 66,298
A/R from related parties 9,194 10,320 418
Advance related parties
Assets for current tax 576 734 339
Assets held for sale 289
Other current assets 12,298 7,004 10,680
Inventories 79,702 62,258 76,880
Total current assets 254,332 223,470 230,562
Non-current assets :
Costs of incorporation
Property, plant and equipment 97,591 92,751 97,411
Financial assets 6 6 6
Intangible fixed assets 6,042 7,245 6,209
A/R directors
Other non-current assets 8 7 7
Deferred tax assets 24,727 9,784 23,970
Total non current assets 128,374 109,793 127,603
Total assets 382,706 333,263 358,165
CONFORM IFRS Quarter ended Quarter ended Year ended
31/03/2017 31/03/2016 31/12/2016
in k EUR audited
Liabilities and shareholders Equity
Current liabilities :
Bank loans and overdrafts
Derivative financial instruments 1,261 1,385 793
Current portion of LT debt 4,005 4,046 4,047
A/P trade 18,578 18,458 19,555
Affiliated companies 16,969 11,285 14,551
Accrued taxes 25,965 6,080 30,160
Accrued expenses and payroll 10,104 9,581 8,603
Other current liabilities 2,808 1,662 2,567
Deferred income 2,247 1,871 2,262
Total current liabilities 81,937 54,369 82,538
Non current liabilities :
LT debt less current portion 11,093 11,091 11,093
Deferred tax liabilities
Other non-current liabilities 2,101 2,153 2,070
Total non current liabilities 13,195 13,245 13,163
Shareholders' equity :
Shareholders' capital 565 565 565
Share premium
Treasury shares -3,818 -3,818 -3,818
Revaluation reserve Hedge -182 -359 -226
Revaluation reserve Fair value
Legal reserve 57 57 57
Retained earnings 272,534 252,380 176,277
Current period's profit 25,442 22,836 96,257
Cumulative translation adjustment -7,034 -6,021 -6,658
Equity attributable to company owners 287,564 265,639 262,454
Non controlling interests 10 10 10
Total shareholders equity 287,574 265,649 262,465
Total liabilities, shareholders' equity
and minority interests
382,706 333,263 358,165

Consolidated Statements of Cash Flow

CONFORM IFRS Quarter ended Quarter ended Year ended
31/03/2017 31/03/2016 31/12/2016
(in k EUR) audited
Cash flow from operating activities
Net income
25,442 22,836 96,257
Adjustments for :
Operating activities 6,200 5,959 14,520
Deferred taxes -757 1,093 -13,093
Capital grants 121 174 896
Depreciation and amortisation 7,220 5,476 25,872
Unrealized exchange results 1,630 -415 -452
Financial result -2,014 -368 1,298
Operating profit before working capital changes 31,642 28,794 110,777
A/R, Trade 5,778 -1,541 -15,047
A/R, affiliates -8,775 -8,321 1,581
Other current assets -1,932 -1,291 -5,147
Other non current assets -1 1 1
Inventories -3,665 1,742 -15,479
A/P -978 3,223 4,323
A/P affiliates 2,418 495 3,760
Accrued expenses 2,674 3,516 29,619
Other current liabilities 232 -1,569 -633
Other non current liabilities 485 -691 -976
Interest paid -94 -69 -294
Income tax -5,368 -1,532 -4,533
Cash flow from operating activities 22,413 22,756 107,951
Cash flow from investing activities
Acquisition of subsidiary, net of cash acquired
Financial fixed assets
Purchase of PPE and intangible assets (netted) -6,390 -7,684 -28,774
Interest received 3 17 172
Investments/proceeds/ from current investments 158 -109
(incl. financial instruments)
Cash provided from investing activities -6,229 -7,667 -28,711
Cash flows from financing activities
Payment to acquire own shares
Proceeds/Repayment of long-and short-term debt -42 -47 -46
Proceeds/Repayment of bank loans and overdrafts
Proceeds from (repayment of) related party financing
Impact of exchange results on financing items 115 1,114 -1,135
Dividend payment -76,102
Capital Decrease
Non controlling interests
Cash provided from financing activities 73 1,068 -77,284
CTA -2 -14 -5
Increase/decrease in cash and cash equivalents 16,255 16,143 1,952
Cash at beginning of the period
Cash at the end of the period
75,789
92,045
73,838
89,981
73,838
75,789

Sales per Geography

Q1/17 Q1/16 Q4/16 FY 2016
APAC
Asia Pacific
48% 43% 51% 47%
EMEA
Europe - Middle-East - Africa
40% 43% 37% 39%
NALA
North America - Latin America
12% 14% 12% 14%
TOTAL 100% 100% 100% 100%

Talk to a Data Expert

Have a question? We'll get back to you promptly.